ExodusPoint Capital Management’s BioCryst Pharmaceuticals BCRX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $1.89M | Buy |
210,840
+149,907
| +246% | +$1.34M | 0.02% | 714 |
|
|
2025
Q1 | $457K | Buy |
+60,933
| New | +$457K | ﹤0.01% | 1067 |
|
|
2024
Q2 | – | Sell |
-172,961
| Closed | -$879K | – | 1398 |
|
|
2024
Q1 | $879K | Sell |
172,961
-19,241
| -10% | -$97.8K | 0.01% | 877 |
|
|
2023
Q4 | $1.15M | Sell |
192,202
-557,851
| -74% | -$3.34M | 0.01% | 705 |
|
|
2023
Q3 | $5.31M | Sell |
750,053
-462,494
| -38% | -$3.27M | 0.05% | 332 |
|
|
2023
Q2 | $8.54M | Sell |
1,212,547
-9,134
| -0.7% | -$64.3K | 0.07% | 249 |
|
|
2023
Q1 | $10.2M | Buy |
1,221,681
+1,199,839
| +5,493% | +$10M | 0.08% | 215 |
|
|
2022
Q4 | $251K | Sell |
21,842
-687,443
| -97% | -$7.9M | ﹤0.01% | 1352 |
|
|
2022
Q3 | $8.94M | Buy |
709,285
+366
| +0.1% | +$4.61K | 0.12% | 220 |
|
|
2022
Q2 | $7.5M | Buy |
+708,919
| New | +$7.5M | 0.09% | 254 |
|
|
2022
Q1 | – | Sell |
-120,827
| Closed | -$1.67M | – | 2133 |
|
|
2021
Q4 | $1.67M | Buy |
120,827
+78,532
| +186% | +$1.09M | 0.02% | 802 |
|
|
2021
Q3 | $608K | Sell |
42,295
-79,308
| -65% | -$1.14M | 0.01% | 1232 |
|
|
2021
Q2 | $1.92M | Buy |
+121,603
| New | +$1.92M | 0.02% | 646 |
|
|
2020
Q3 | – | Sell |
-35,969
| Closed | -$171K | – | 1682 |
|
|
2020
Q2 | $171K | Buy |
+35,969
| New | +$171K | ﹤0.01% | 1521 |
|